Schrodinger Net Change in Short-term Investments 2019-2025 | SDGR
Schrodinger net change in short-term investments from 2019 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
| Schrodinger Annual Net Change in Short-term Investments (Millions of US $) |
|
|---|---|
| 2024 | $N/A |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| 2018 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.869B | $0.208B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.097B | 58.90 |
| Hims & Hers Health (HIMS) | United States | $12.727B | 132.23 |
| Tempus AI (TEM) | United States | $11.588B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.708B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.030B | 62.97 |
| Hinge Health (HNGE) | United States | $2.965B | 0.00 |
| Privia Health (PRVA) | United States | $2.833B | 193.67 |
| Enovis (ENOV) | United States | $1.879B | 10.48 |
| Phreesia (PHR) | United States | $1.636B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.517B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 26.18 |
| Azenta (AZTA) | United States | $1.340B | 62.30 |
| 10x Genomics (TXG) | United States | $1.242B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.664B | 0.00 |
| Claritev (CTEV) | United States | $0.633B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.549B | 164.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| Outset Medical (OM) | United States | $0.376B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 805.67 |
| Health Catalyst (HCAT) | United States | $0.290B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.139B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.092B | 3.52 |
| 111 (YI) | China | $0.072B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |